In a groundbreaking development for HIV prevention, a new drug called Yeztugo has been approved as the first-ever twice-yearly injection…
Browsing: PrEP
An annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully completed an important early safety trial. The…
The HIV prevalence rate among individuals aged 15 to 34 is on the rise, with low condom usage playing a…
Despite decades of global efforts, HIV/AIDS continues to be a significant public health challenge, with millions of people still living…
Australia is currently experiencing a significant shortage of the HIV-prevention drug PrEP (pre-exposure prophylaxis), prompting concerns among health experts and…
In eastern and southern Africa, young women are disproportionately affected by new HIV infections, highlighting a critical public health challenge…